Trifecta Capital Advisors, LLC Vertex Pharmaceuticals Inc Transaction History
Trifecta Capital Advisors, LLC
- $477 Billion
- Q1 2025
A detailed history of Trifecta Capital Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 14,538 shares of VRTX stock, worth $7.41 Million. This represents 1.48% of its overall portfolio holdings.
Number of Shares
14,538
Previous 13,965
4.1%
Holding current value
$7.41 Million
Previous $5.62 Billion
25.33%
% of portfolio
1.48%
Previous 1.11%
Shares
10 transactions
Others Institutions Holding VRTX
# of Institutions
1,804Shares Held
223MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$14.4 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.9 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.9 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$6.1 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.31 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $131B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...